The current YMAB market cap is 214.79M. The company's latest EPS is USD -0.6561 and P/E is -7.61.
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 20.75M | 34.9M | 65.27M | 84.82M | 87.69M |
Operating Income | -119.94M | -115.43M | -94.85M | -25.67M | -31.2M |
Net Income | -119.34M | -55.28M | -95.61M | -21.43M | -29.67M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 132.05M | 212.78M | 141.46M | 127.87M | 119.9M |
Total Liabilities | 26.21M | 32.68M | 32.24M | 26.88M | 27.9M |
Total Equity | 105.84M | 180.11M | 109.22M | 100.99M | 92M |
Market Cap | 214.79M |
Price to Earnings Ratio | -7.61 |
Price to Sales Ratio | 2.57 |
Price to Cash Ratio | 3.36 |
Price to Book Ratio | 2.45 |
Dividend Yield | - |
Shares Outstanding | 45.22M |
Average Volume (1 week) | 250.72k |
Average Volume (1 Month) | 335.93k |
52 Week Change | -69.82% |
52 Week High | 17.7775 |
52 Week Low | 4.25 |
Spread (Intraday) | 1.85 (33.04%) |
Company Name | Y mAbs Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.ymabs.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions